AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Weight Loss Drug Market Competition and Medical Benefits
The chapter explores the competition between pharmaceutical companies like Novo Nordisk and Eli Lilly in the weight loss drug market, focusing on their strategies to fulfill the increasing demand for their products. It also delves into the medical benefits of weight loss drugs, particularly the impact of a drug named Wigovi in treating heart-related issues and the optimism surrounding its potential to prevent cardiovascular diseases, leading to predictions of a billion-dollar market by 2033.